Back to 
Renaissance Technologies LLC
Renaissance Technologies LLCPRPRAX
Showing 0 of 11 quarters
Position history for Renaissance Technologies LLC's holdings in Praxis Precision Medicines, Inc.
As of its Q3 2023 13F, Renaissance Technologies held 977,000 shares of PRAX (Praxis Precision Medicines), worth $1.7M. Renaissance Technologies' 13F filings listed PRAX from Q4 2021 to Q3 2023, 8 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.